ホーム > 市場調査レポート > バイオテクノロジー > ゲノム創薬 > 世界のRNA干渉市場 - 現在と未来の展望
カテゴリ
バイオテクノロジー (1623)
オーダーメイド医療 (51)
ゲノム創薬 (202)
バイオマーカー (158)
バイオマテリアル (54)
バイオ機器 (380)
遺伝子療法/RNAi (102)
抗体/免疫 (194)
再生医療 (122)
分子標的療法 (131)
市場調査レポート

世界のRNA干渉市場 - 現在と未来の展望

World RNAi Markets - Current and Future Outlook

発行 Frost & Sullivan
出版日 2004年07月 商品コード 22501
ページ情報 英文  
価格
こちらの商品の販売は終了いたしました。

当商品の販売は、2011年07月19日を持ちまして終了しました。

原文目次

Abstract

The objective of this research service is to provide detailed analysis of the relatively small but rapidly emerging global RNAi market. The research service discusses the approaches to delivery of siRNA into cells, tissues and organs. In addition, this service provides an in-depth analysis of the global RNAi market split into four segments - RNA oligonucleotides market, vector-based siRNA market, therapeutic market and contract service market.The research service also discusses the competitive landscape and provides strategies for companies involved in the RNAi market as well as for companies wishing to enter this extremely lucrative market. The research service also provides decision support databases related to biotechnology.

Table of Contents

  • EXECUTIVE SUMMARY
    • Executive Summary
      • Executive Summary
  • GLOSSARY OF TERMS
    • Abbreviations
      • Abbreviations
  • RESEARCH AND FORECASTING METHODOLOGY
    • Frost & Sullivan's 12-step Market Engineering Research Methodology
      • Frost & Sullivan's 12-step Market Engineering Research Methodology
      • Step 1: Define Market Problems; Needs and Opportunities
      • Step 2: Define Objectives and Goals of the Research Project
      • Step 3: Design Optimal Research Team
      • Step 4: Launch Data Collection Phase
      • Step 5: Select Interview Strategy and Design of Survey
      • Step 6: Test the Survey Design
      • Step 7: Conduct Primary Market Research
      • Step 8: Research Analysis: Finding "Point A"
      • Step 9: Market Forecasting: Finding "Point B"
      • Step 10: Develop Strategic Recommendations
      • Step 11: Confirm Results with Quality Control
      • Step 12: Market Monitoring and Customer Feedback Review
    • Frost & Sullivan's Market Engineering Forecasting Methodology
      • Overview
      • Strategic Significance of the Market Engineering Forecast
      • Judging Credibility and Accuracy of Market Engineering Forecasts
      • Forecast Assumptions
  • INTRODUCTION TO RNAI
    • Background
      • Background
    • Gene Silencing
      • Gene Silencing
    • Technologies for Gene Silencing
      • Technologies for Gene Silencing
      • Aptamers
      • Ribozymes
      • Peptide Nucleic Acid (PNA) and PNA-DNA Chimeras
      • Antisense Oligonucleotides
      • CpG Oligonucleotides
      • RNA Interference (RNAi)
    • Comparision of Gene-silencing Approaches
      • Comparison of Gene-silencing Approaches
    • RNAi
      • Introduction
      • RNAi Discovery
      • RNAi Approaches
  • METHODS OF DELIVERY
    • Introduction
      • Introduction
    • Delivery Technologies
      • Delivery by Chemical Transfections
      • Delivery by Electroporation
      • Delivery Using Plasmid and Viral Vectors
      • Delivery Using Cell-Penetrating Peptides
      • In Vivo Delivery of siRNAs
  • INDUSTRY CHALLENGES
    • Industry Challenges and Issues
      • Challenges Facing the World RNAi Market
    • Time Frame Analysis
      • Time-frame Analysis of Industry Challenges
  • STRATEGIC ANALYSIS OF THE GLOBAL RNAI MARKET
    • Introduction
      • Introduction
    • Research Measurement System
      • Research Measurement System
    • Market Drivers and Restraints
      • Market Drivers
      • Market Restraints
    • Market Forecast
      • Total RNAi Market
      • RNA Oligonucleotide Market
      • Vector-based siRNA Market
      • RNAi Therapeutic Market
      • RNAi Contract Service Market
    • Trends by Application
      • Trends by Application
      • Academia Versus Pharma-biotech
    • Geographic Trends in the RNAi Markets
      • Trends by Geographic Region
    • Pricing Analysis
      • Pricing Analysis
  • COMPETITIVE ENVIRONMENT
    • Competitive Structure
      • Competitive Structure
    • Market Share Analysis
      • Market Share Analysis
  • MARKET ENGINEERING STRATEGY
    • Introduction to Strategic Recommendations
      • Introduction to Strategic Recommendations
    • Strategic Analysis
      • Market Maturation Process
      • Strategic Anticipation
      • Customer Priorities
    • Strategic Recommendations
      • Porters Five Forces Analysis and Recommendations
      • Technical Strategic Recommendations
      • Recommendations for the Sales and Marketing Department
      • Other Strategic Recommendations
  • FROST & SULLIVAN AWARDS FOR THE RNAI MARKET
    • Awards for the Global RNAi Markets
      • Frost & Sullivan Awards
      • Business Development Strategy Leadership Award
      • Product Differentiation Innovation Award
      • Product Quality Leadership Award
      • Market Leadership Award
      • Growth Strategy Leadership Award
  • DATABASE OF KEY INDUSTRY PARTICIPANTS
    • Companies Exploiting RNAi Therapeutics
      • Companies Exploiting RNAi Therapeutics
    • Companies Exploiting RNAi Screening
      • Companies Exploiting RNAi Screening
    • Suppliers of RNAi Tools and Reagents
      • Suppliers of RNAi Tools and Reagents
  • DECISION SUPPORT DATABASES
    • Number of Biotech Companies
      • Number of Biotech Companies
    • Government R&D Investment in Biotechnology
      • Government R&D Investment in Biotechnology
    • Private Investment in Biotechnology
      • Private Investment in Biotechnology
    • Pharmaceutical R&D Expenditure
      • Pharmaceutical R&D Expenditure
Back to Top